Environmental pollutants in blood linked to ALS risk, survival
A person’s degree of exposure to multiple environmental pollutants — reflected by their presence in the blood — may be…
Articles by Lindsey Shapiro, PhD
Man with ALS controls devices using brain-computer interface
A man with amyotrophic lateral sclerosis (ALS) was able to control external devices — lighting and a TV —…
BrainStorm making cuts to support new trial, advance NurOwn for ALS
BrainStorm Cell Therapeutics is making strategic adjustments — including cuts in its workforce — to accelerate the clinical…
Muscle strength correlated with functional outcomes in Phase 2 analysis
Direct measures of muscle strength were correlated with functional abilities among amyotrophic lateral sclerosis (ALS) patients in a Phase…
Takeda acquires license to ALS therapy aimed at toxic TDP-43
Takeda has obtained an exclusive, worldwide license to AcuraStem’s investigational therapies targeting the PIKfyve enzyme, including…
Trial of brain-computer interface device for ALS now enrolling
Neuralink is recruiting participants — including people with amyotrophic lateral sclerosis (ALS) — for the first-in-human trial of…
Long-term ALS survival benefit with CNM-Au8 seen in trial analyses
Up to about 2.5 years of treatment with CNM-Au8 in an open-label extension of the HEALEY ALS platform trial…
Disaster preparedness insufficient among patients, caregivers in Japan
Disaster preparedness, including stockpiling goods, owning and knowing how to use emergency equipment, and being aware of community resources, is…
NLRP3 inhibition alone does not ease ALS inflammation: Study
Inhibiting the NLRP3 inflammasome — an immune system protein complex believed to contribute to the inflammation that drives amyotrophic…
CNM-Au8 seen to extend survival by more than 1.5 years in ALS trial
Treatment with CNM-Au8 was found to significantly delay disease progression and prolong survival, by more than 1.5 years, among…